Martin Stockmann
Overview
Explore the profile of Martin Stockmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stockmann M, Lock J, Vondran F, Seehofer D
Eur J Surg Oncol
. 2024 Sep;
50(12):108697.
PMID: 39305809
No abstract available.
2.
Primavesi F, Maglione M, Cipriani F, Denecke T, Oberkofler C, Starlinger P, et al.
Br J Surg
. 2023 Aug;
110(10):1331-1347.
PMID: 37572099
Background: Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus...
3.
Schleiger A, Kramer P, Sallmon H, Jentsch N, Pileckaite M, Danne F, et al.
Front Cardiovasc Med
. 2022 Sep;
9:952080.
PMID: 36158803
Background: Despite improved survival a substantial number of Fontan patients eventually develop late failure. Fontan-associated liver disease (FALD) is the most frequent end-organ dysfunction. Although impaired hemodynamics and Fontan failure...
4.
Schutte A, Diessel L, Stockmann M, Walldorf J
Chirurgie (Heidelb)
. 2022 Apr;
93(8):805-809.
PMID: 35359244
No abstract available.
5.
Schleiger A, Kramer P, Sallmon H, Jentsch N, Pileckaite M, Danne F, et al.
Front Cardiovasc Med
. 2022 Jan;
8:764009.
PMID: 35004881
Fontan-associated liver disease (FALD) is the most common end-organ dysfunction affecting up to 70-80% of the Fontan population. The clinical significance of FALD is incompletely understood and no unambiguous correlation...
6.
Alraish R, Wicha S, Frey O, Roehr A, Pratschke J, Stockmann M, et al.
Technol Health Care
. 2021 Jun;
30(2):309-321.
PMID: 34180433
Background: Critically ill patients commonly suffer from infections that require antimicrobial therapy. In previous studies, liver dysfunction was shown to have an essential impact on the dose selection in these...
7.
Berndt N, Eckstein J, Heucke N, Wuensch T, Gajowski R, Stockmann M, et al.
FEBS J
. 2020 Oct;
288(7):2332-2346.
PMID: 33030799
Metabolic reprogramming is a characteristic feature of cancer cells, but there is no unique metabolic program for all tumors. Genetic and gene expression studies have revealed heterogeneous inter- and intratumor...
8.
Dziodzio T, Ollinger R, Schoning W, Rothkappel A, Nikolov R, Juraszek A, et al.
BMC Gastroenterol
. 2020 Aug;
20(1):265.
PMID: 32787947
Background: MELD score and MELD score derivates are used to objectify and grade the risk of liver-related death in patients with liver cirrhosis. We recently proposed a new predictive model...
9.
Alraish R, Wicha S, Frey O, Roehr A, Pratschke J, Stockmann M, et al.
Ann Intensive Care
. 2020 Aug;
10(1):106.
PMID: 32754775
Background: In critically ill patients, tigecycline (TGC) remains an important therapeutic option due to its efficacy against multiresistant Gram-positive and Gram-negative bacteria. TGC is metabolized and eliminated predominantly by the...
10.
Wuensch T, Wizenty J, Quint J, Spitz W, Bosma M, Becker O, et al.
Gastroenterol Res Pract
. 2020 Jul;
2020:8691904.
PMID: 32676107
[This corrects the article DOI: 10.1155/2019/3784172.].